Search - tctmd.com

Displaying 301 - 320 of 963

Sort: Relevancy | Date

Presentation TCT 2017

Are All Contemporary DES Comparable? Lessons From the SORT-OUT Trials

Presenter: Giulio G. Stefanini, Stephan Windecker, Evald H. Christiansen

October 30, 2017

Presentation TCT 2017

When Two Stents Are Indicated: DK Crush Technique Step-by-step (With Case Examples)

Presenter: Terje K. Steigen, Leif Thuesen, Nai-Liang Tian

October 30, 2017

Presentation TCT 2017

Topic 1: How Should We Evaluate Technologies in Their Infancy? TAVR, Renal Denervation, BVS, LAA Closure, Mechanical Circulatory Support, and More

Presenter: Robert A. Byrne, Gregg W. Stone, Aaron V. Kaplan

October 30, 2017

Presentation TCT 2017

Are There Meaningful Differences Between Current Durable Polymer-Based vs Bioabsorbable Polymer-Based vs Polymer-Free Metallic DES? Pathologic Insights

Presenter: Giulio G. Stefanini, Stephan Windecker, Renu Virmani

October 30, 2017

Presentation TCT 2017

Promus Element Everolimus-Eluting Stents: Device Iterations and Randomized/Registry Outcomes Data in Perspective

Presenter: Stephen G. Ellis, David E. Kandzari, Sigmund Silber

October 30, 2017

Presentation TCT 2017

When Two Stents Are Indicated: TAP Technique Step-by-step (With Case Examples)

Presenter: Terje K. Steigen, Leif Thuesen, Francesco Burzotta

October 30, 2017

Presentation TCT 2017

When Two Stents Are Indicated: Culotte Technique Step-by-step (With Case Examples)

Presenter: Terje K. Steigen, Leif Thuesen, Ioannis Iakovou

October 30, 2017

Presentation TCT 2017

XIENCE Everolimus-Eluting Stents: Device Iterations, Randomized/Registry Outcomes Data in Perspective and the Move to Shorter DAPT

Presenter: Stephen G. Ellis, David E. Kandzari, Tullio Palmerini

October 30, 2017

Presentation TCT 2017

Mortality and Stroke After PCI vs CABG In Left Main and 3VD: An Individual Patient Data Meta-analysis

Presenter: Dean J. Kereiakes, Spencer B. King III, A. Pieter Kappetein

October 30, 2017

Presentation TCT 2017

Counterpoint Access to Modern Valve Therapies for Underserved Populations Trumps Arbitrary Guidelines Favoring High-Volume Urban Centers!

Presenter: Uzoma Ibebuogu

October 30, 2017

Presentation TCT 2017

Influence of Diversity: Should Sex, Race, and Ethnicity Affect Revascularization Decisions? Does It?

Presenter: Dean J. Kereiakes, Spencer B. King III, Roxana Mehran

October 30, 2017

Presentation TCT 2017

Alternatives to Traditional P-value Testing: Bayesian Designs

Presenter: Eugene H. Blackstone, Stuart J. Pocock, Roseann M White

October 30, 2017

Presentation TCT 2017

Point A Tiered Centers of Excellence Approach Makes Sense!

Presenter: Patrick T. O'Gara

October 30, 2017

Presentation TCT 2017

Beyond Time-to-First Event: Counting Multiple Events, Hierarchical Measures, and Weighted Composites

Presenter: Eugene H. Blackstone, Stuart J. Pocock, Jan G. P. Tijssen

October 30, 2017

Presentation TCT 2017

Impact of Mandatory Stent Price Controls 2: My New Insights From Inside Industry

Presenter: Dean J. Kereiakes, Spencer B. King III, Ian T. Meredith

October 30, 2017

Presentation TCT 2017

Counterpoint In the Modern Era, Crowd Wisdom, Cumulative Experience and New Technology Trumps Case Volume!

Presenter: Martin B. Leon

October 30, 2017

Presentation TCT 2017

Bifurcation Stents 1: TRYTON Description, Data, and Case Examples

Presenter: Alaide Chieffo, Jeffrey W. Moses, Philippe Genereux

October 30, 2017

Presentation TCT 2017

Impact of Mandatory Stent Price Controls 1: Physician Perspectives

Presenter: Dean J. Kereiakes, Spencer B. King III, Upendra Kaul

October 30, 2017

Presentation TCT 2017

Proper and Improper Interpretations of the P-value

Presenter: Eugene H. Blackstone, Stuart J. Pocock

October 30, 2017

Presentation TCT 2017

Point - Clearly, The More You Do, The Better You Are!

Presenter: John D. Carroll

October 30, 2017

Advertisement

Are All Contemporary DES Comparable? Lessons From the SORT-OUT Trials

When Two Stents Are Indicated: DK Crush Technique Step-by-step (With Case Examples)

Topic 1: How Should We Evaluate Technologies in Their Infancy? TAVR, Renal Denervation, BVS, LAA Closure, Mechanical Circulatory Support, and More

Are There Meaningful Differences Between Current Durable Polymer-Based vs Bioabsorbable Polymer-Based vs Polymer-Free Metallic DES? Pathologic Insights

Promus Element Everolimus-Eluting Stents: Device Iterations and Randomized/Registry Outcomes Data in Perspective

When Two Stents Are Indicated: TAP Technique Step-by-step (With Case Examples)

When Two Stents Are Indicated: Culotte Technique Step-by-step (With Case Examples)

XIENCE Everolimus-Eluting Stents: Device Iterations, Randomized/Registry Outcomes Data in Perspective and the Move to Shorter DAPT

Mortality and Stroke After PCI vs CABG In Left Main and 3VD: An Individual Patient Data Meta-analysis

Counterpoint Access to Modern Valve Therapies for Underserved Populations Trumps Arbitrary Guidelines Favoring High-Volume Urban Centers!

Influence of Diversity: Should Sex, Race, and Ethnicity Affect Revascularization Decisions? Does It?

Alternatives to Traditional P-value Testing: Bayesian Designs

Point A Tiered Centers of Excellence Approach Makes Sense!

Beyond Time-to-First Event: Counting Multiple Events, Hierarchical Measures, and Weighted Composites

Impact of Mandatory Stent Price Controls 2: My New Insights From Inside Industry

Counterpoint In the Modern Era, Crowd Wisdom, Cumulative Experience and New Technology Trumps Case Volume!

Bifurcation Stents 1: TRYTON Description, Data, and Case Examples

Impact of Mandatory Stent Price Controls 1: Physician Perspectives

Proper and Improper Interpretations of the P-value

Point - Clearly, The More You Do, The Better You Are!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content